SEC 13F Intelligence

Managers / Q2 2020 · view latest →

ARMISTICE CAPITAL, LLC

CIK 0001601086 · 510 MADISON AVENUE, 7TH FLOOR, NEW YORK, NY, 10022 · (212) 231-4932

Reported Value
$2.3B
Q2 2020
Positions
79
Filings on Record
26
2019–present window
Filed
Aug 14, 2020
original filing

Summary

Armistice Capital, LLC reported $2.3B in U.S.-listed holdings across 79 positions for Q2 2020.

Its largest position, Cerecor, represents 3.4% of the portfolio.

Compared with Q1 2020, the fund opened 19 new positions and exited 18.

Portfolio Metrics

Turnover
+13.9%
vs prior filed quarter
Top-10 Concentration
+25.3%
share of reported value
Largest Position
+3.4%
Cerecor
New / Exited
19 / 18
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’20: $1.6BQ1 ’20Q2 ’20: $2.3BQ3 ’20: $2.8BQ4 ’20: $2.2BQ1 ’21: $4.4BQ1 ’21Q2 ’21: $5.6BQ3 ’21: $5.9BQ4 ’21: $6.1BQ1 ’22: $5.2BQ1 ’22Q2 ’22: $5.7BQ3 ’22: $5.8BQ4 ’22: $5.7BQ1 ’23: $6.9BQ1 ’23Q2 ’23: $6.9BQ3 ’23: $6.5BQ4 ’23: $7.3BQ1 ’24: $7.5BQ1 ’24Q2 ’24: $7.9BQ3 ’24: $6.3BQ4 ’24: $7.3BQ1 ’25: $6.7BQ1 ’25Q2 ’25: $5.8BQ3 ’25: $6.7BQ4 ’25: $8.4BQ1 ’26: $5.6BQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 71.8%ETP: 16.3%Other: 11.2%ADR: 0.7%
  • Common Stock · 71.8% · $1.6B
  • ETP · 16.3% · $372M
  • Other · 11.2% · $255M
  • ADR · 0.7% · $15M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MEDTRONIC PLCNEW+592.0K592.0K+$54M$54M
AZOAUTOZONE INCNEW+28.0K28.0K+$32M$32M
BBYBEST BUY INCNEW+331.9K331.9K+$29M$29M
ZYMEUSDZYMEWORKS INCNEW+778.0K778.0K+$28M$28M
WOOFOOT LOCKER INCNEW+814.7K814.7K+$24M$24M
BCORUSDBLUCORA INCNEW+2.05M2.05M+$23M$23M
ORLYOREILLY AUTOMOTIVE INCNEW+36.6K36.6K+$15M$15M
ARGXARGENX SENEW+68.0K68.0K+$15M$15M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2020

48 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CERECOR INCCOM3.41%$78M29.91M
2UNHUNITEDHEALTH GROUP INChistory →COM2.59%$59M200.0K
3BMYBRISTOL-MYERS SQUIBB COhistory →COM2.58%$59M1.00M
4BIIBBIOGEN INChistory →COM2.53%$58M216.0K
5ALXNALEXION PHARMACEUTICALS INChistory →COM2.46%$56M500.0K
6VNDAVANDA PHARMACEUTICALS INChistory →COM2.41%$55M4.80M
7ENRENERGIZER HLDGS INC NEWhistory →COM2.39%$55M1.15M
8MEDTRONIC PLCSHS2.38%$54M592.0K
9SUPNSUPERNUS PHARMACEUTICALS INChistory →COM2.30%$52M2.21M
10LNTHLANTHEUS HLDGS INChistory →COM2.27%$52M3.62M
11INCYINCYTE CORPhistory →COM1.99%$45M436.0K
12CENTACENTRAL GARDEN & PET COhistory →CL A NON-VTG1.96%$45M1.32M
13REGNREGENERON PHARMACEUTICALShistory →COM1.86%$42M68.0K
14FIVEFIVE BELOW INChistory →COM1.77%$40M378.0K
15BIOHAVEN PHARMACTL HLDG CO LCOM1.60%$37M500.0K
16DBXDROPBOX INChistory →CL A1.55%$35M1.62M
17DGDOLLAR GEN CORP NEWhistory →COM1.55%$35M185.4K
18ROSTROSS STORES INChistory →COM1.53%$35M409.3K
19BLUEBIRD BIO INCCOM1.52%$35M568.0K
20AMZNAMAZON COM INChistory →COM1.51%$34M12.5K
21ATRAPTARGROUP INChistory →COM1.41%$32M288.0K
22AZOAUTOZONE INChistory →COM1.39%$32M28.0K
23AMAGAMAG PHARMACEUTICALS INChistory →COM1.38%$32M4.12M
24MRTXEURMIRATI THERAPEUTICS INChistory →COM1.36%$31M272.0K
25BBYBEST BUY INChistory →COM1.27%$29M331.9K
26CN2CATALYST PHARMACEUTICALS INChistory →COM1.26%$29M6.20M
27BURLBURLINGTON STORES INChistory →COM1.26%$29M145.4K
28MDGLMADRIGAL PHARMACEUTICALS INChistory →COM1.23%$28M248.0K
29ZYMEUSDZYMEWORKS INChistory →COM1.23%$28M778.0K
30MRKMERCK & CO. INChistory →COM1.22%$28M360.0K
31TWNKEURHOSTESS BRANDS INChistory →CL A1.22%$28M2.28M
32CLCOLGATE PALMOLIVE COhistory →COM1.18%$27M368.0K
33FTDRFRONTDOOR INChistory →COM1.15%$26M592.0K
34VYGRVOYAGER THERAPEUTICS INChistory →COM1.15%$26M2.08M
35KHCKRAFT HEINZ COhistory →COM1.12%$26M800.0K
36PTCTPTC THERAPEUTICS INChistory →COM1.11%$25M500.0K
37CMGCHIPOTLE MEXICAN GRILL INChistory →COM1.11%$25M24.0K
38WOOFOOT LOCKER INChistory →COM1.04%$24M814.7K
39BCORUSDBLUCORA INChistory →COM1.03%$23M2.05M
40UBERUBER TECHNOLOGIES INChistory →COM1.00%$23M736.0K
41AVYAUSDAVAYA HLDGS CORPhistory →COM1.00%$23M1.84M
42MDLZMONDELEZ INTL INChistory →CL A0.96%$22M428.0K
43KFYKORN FERRYhistory →COM NEW0.96%$22M712.0K
44EPCEDGEWELL PERS CARE COhistory →COM0.96%$22M700.0K
45CPBCAMPBELL SOUP COhistory →COM0.95%$22M436.0K
46SMARGBPSMARTSHEET INChistory →COM CL A0.93%$21M416.0K
47LOWLOWES COS INChistory →COM0.80%$18M135.4K
48ENTAENANTA PHARMACEUTICALS INChistory →COM0.71%$16M324.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$5.6B267May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$8.4B370Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$6.7B332Nov 17, 202513F-HRchanges · EDGAR ↗
Q2 2025$5.8B210Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$6.7B230May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$7.3B232Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$6.3B259Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$7.9B254Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$7.5B337May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$7.3B297Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$6.5B254Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$6.9B222Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$6.9B226May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$5.7B193Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$5.8B197Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$5.7B176Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$5.2B141May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$6.1B145Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$5.9B139Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$5.6B116Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.4B111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$2.2B104Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$2.8B101Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$2.3B79Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$1.6B79May 15, 202013F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • Armistice Capital Master Fund Ltd.028-16739

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.